FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085166 [Registered on: 21/04/2025] Trial Registered Prospectively
Last Modified On: 01/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Role of Saindhavaadi Bidalaka And Yashtigairikaadi Bidalaka In The Management of Klinnavartma w.s.r. to Blepharitis 
Scientific Title of Study   A Comparative Clinical Study To Evaluate The Efficacy Of Saindhavaadi Bidalaka And Yashtigairikaadi Bidalaka In The Management Of Klinnavartma w.s.r. to Blepharitis 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Bhavya Singh Rana 
Designation  PG Scholar 
Affiliation  Mansarovar Ayurvedic Medical College Hospital and Research Centre, Bhopal, MADHYA PRADESH  
Address  Fourth Floor Room No. 2, Department Of Shalakya Tantra, Mansarovar Ayurvedic Medical College Hospital and Research Centre, Bhopal, MADHYA PRADESH 462042 India Bhopal MADHYA PRADESH 462042 India

Bhopal
MADHYA PRADESH
462042
India 
Phone  7987280998  
Fax    
Email  drbhavyasrana82@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shubhangi Lohakare 
Designation  Professor 
Affiliation  Mansarovar Ayurvedic Medical College Hospital and Research Centre, Bhopal, MADHYA PRADESH  
Address  Fourth Floor Room No. 2, Department Of Shalakya Tantra, Mansarovar Ayurvedic Medical College Hospital and Research Centre, Bhopal, MADHYA PRADESH 462042 India Bhopal MADHYA PRADESH 462042 India

Bhopal
MADHYA PRADESH
462042
India 
Phone  9890698452  
Fax    
Email  shindeshubh84@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Bhavya Singh Rana 
Designation  PG Scholar 
Affiliation  Mansarovar Ayurvedic Medical College Hospital and Research Centre, Bhopal, MADHYA PRADESH  
Address  Fourth Floor Room No. 2, Department Of Shalakya Tantra, Mansarovar Ayurvedic Medical College Hospital and Research Centre, Bhopal, MADHYA PRADESH 462042 India Bhopal MADHYA PRADESH 462042 India

Bhopal
MADHYA PRADESH
462042
India 
Phone  7987280998  
Fax    
Email  drbhavyasrana82@gmail.com  
 
Source of Monetary or Material Support  
Mansarovar Ayurvedic Medical College Hospital and Research Centre, Bhopal 
 
Primary Sponsor  
Name  Mansarovar Ayurvedic Medical College Hospital and Research Centre 
Address  Fourth Floor Room no. 2, Department of Shalakya Tantra, Mansarovar Ayurvedic Medical College Hospital and Research Centre, Hinotiya Alam, Kolar Road, Bhopal, MADHYA PRADESH  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhavya Singh Rana  Mansarovar Ayurvedic Medical College Hospital and Research Centre  Fourth Floor Room No. 2, Department of Shalakya Tantra, Mansarovar Ayurvedic Medical College Hospital and Research Centre, Bhopal, MADHYA PRADESH 462042 India Bhopal MADHYA PRADESH
Bhopal
MADHYA PRADESH 
7987380998

drbhavyasrana82@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Mansarovar Ayurvedic Medical College Hospital and Research Centre  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H010||Blepharitis. Ayurveda Condition: PRAKLINNAVARTMA/KAPOTKLISHTA-VARTMA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-biDAlaka:, बिडालक: (Procedure Reference: Chakra Dutt, Procedure details: A lukewarm paste will be applied on the outer skin around the eyes, excluding the eyelashes.)
(1) Medicine Name: Saindhavaadi Bidalaka, Reference: Chakra Dutt, Route: Topical, Dosage Form: Lepa Churna, Dose: 5(g), Frequency: od, Duration: 7 Days
2Comparator ArmProcedure-biDAlaka:, बिडालक: (Procedure Reference: Sharangdhar Samhita, Procedure details: A lukewarm paste will be applied on the outer skin around the eyes, excluding the eyelashes.)
(1) Medicine Name: Yashtigairikaadi Bidalaka, Reference: Sharangdhar Samhita, Route: Topical, Dosage Form: Lepa Churna, Dose: 5(g), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patient having signs and symptoms of Klinnavartma w.s.r. to Blepharitis. 
 
ExclusionCriteria 
Details  Age below 18 years and above 70 years.
Traumatic Eye Injury and recent Eye Surgery.
Chronic infections and Ocular Allergies. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The effect of Saindhavaadi Bidalaka and Yashtigairikaadi Bidalaka in Klinnavartma  7 days 
 
Secondary Outcome  
Outcome  TimePoints 
To study Klinnavartma and Blepharitis and to study the mode of action of Saindhavaadi Bidalaka and Yashtigairikaadi Bidalaka  7 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   22/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Total 60 patients will be randomly selected and divided into 2 groups. One group will be treated with Saindhavaadi Bidalaka, second group will be treated with Yashtigairikaadi Bidalaka in the management of Klinnavartma w.s.r. to Blepharitis. To study deeply about Blepharitis according to modern science and Klinnavartma according to Samhitas. Klinnavartma is a condition affecting the eyelid, making local application a suitable treatment approach. 
Close